Millions of People With Medicare Drug Coverage to Save With New Cap in 2025
January 16, 2025
A new report from the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) projects that
Celebrating 35 years of making Medicare more accessible, affordable, and equitable!
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
Medicare in 2025: Key Changes and Updates
January 9, 2025
Annual changes to premiums and cost-sharing, as well as the continued rollout of significant Part D reforms included in the
Some People Losing “Deemed” Status for the Low-Income Subsidy Remain Eligible for Assistance
November 21, 2024
What Is the Low-Income Subsidy (LIS)? The Low-Income Subsidy (LIS), also called Extra Help, is a federally administered assistance program
Millions See Cost Savings Under the Inflation Reduction Act
October 24, 2024
The Inflation Reduction Act (IRA) made significant improvements to Medicare prescription drug access and affordability, including by restructuring the Part
Comparing Plans is Especially Important This Open Enrollment Season Due to Changes in Part D Protections and New Options
October 17, 2024
Key components of the Inflation Reduction Act’s Part D reforms will be fully implemented for plans offered in 2025. These
Changes in Drug Coverage Coming in 2025 Could Influence Your Choice of Plan
October 10, 2024
Medicare open enrollment is just around the corner, and there will be major changes in 2025 that beneficiaries should keep in mind, and some of these changes may affect what plans people choose.
Medicare Rights Supports Building on the IRA’s Cost Protections for People With Medicare and Other Coverage
September 19, 2024
On Monday, Medicare Rights Center President Fred Riccardi participated in a press conference with Senator Kirsten Gillibrand. He spoke about the importance of key Inflation Reduction Act (IRA) cost protections for people with Medicare, in particular the law’s safeguards against unlimited enrollee expenses for covered Part D drugs.
Medicare Rights Supports Legislation Extending Inflation Reduction Act Affordability Reforms to the Commercial Market
September 16, 2024
Today, Medicare Rights Center President Fred Riccardi spoke in support of the Capping Prescription Costs Act (S. 4671/H.R. 6347), legislation to extend key Inflation Reduction Act reforms to people with group health and marketplace plans.
Medicare Rights Center Celebrates the Anniversary of the Inflation Reduction Act and Applauds Monumental Prescription Drug Savings
August 15, 2024
–Statement by Fred Riccardi, president of the Medicare Rights Center– New York, NY—As we celebrate two years since the passage
Biden-Harris Administration Announces Billions in Savings from Drug Price Negotiations
August 15, 2024
In a historic first, the Biden-Harris administration today announced the results of the initial round of drug price negotiation made
Millions of People With Medicare Drug Coverage to Save With New Cap in 2025
January 16, 2025
A new report from the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) projects that
Medicare in 2025: Key Changes and Updates
January 9, 2025
Annual changes to premiums and cost-sharing, as well as the continued rollout of significant Part D reforms included in the
Some People Losing “Deemed” Status for the Low-Income Subsidy Remain Eligible for Assistance
November 21, 2024
What Is the Low-Income Subsidy (LIS)? The Low-Income Subsidy (LIS), also called Extra Help, is a federally administered assistance program
Millions See Cost Savings Under the Inflation Reduction Act
October 24, 2024
The Inflation Reduction Act (IRA) made significant improvements to Medicare prescription drug access and affordability, including by restructuring the Part
Comparing Plans is Especially Important This Open Enrollment Season Due to Changes in Part D Protections and New Options
October 17, 2024
Key components of the Inflation Reduction Act’s Part D reforms will be fully implemented for plans offered in 2025. These
Changes in Drug Coverage Coming in 2025 Could Influence Your Choice of Plan
October 10, 2024
Medicare open enrollment is just around the corner, and there will be major changes in 2025 that beneficiaries should keep in mind, and some of these changes may affect what plans people choose.
Medicare Rights Supports Building on the IRA’s Cost Protections for People With Medicare and Other Coverage
September 19, 2024
On Monday, Medicare Rights Center President Fred Riccardi participated in a press conference with Senator Kirsten Gillibrand. He spoke about the importance of key Inflation Reduction Act (IRA) cost protections for people with Medicare, in particular the law’s safeguards against unlimited enrollee expenses for covered Part D drugs.
Medicare Rights Supports Legislation Extending Inflation Reduction Act Affordability Reforms to the Commercial Market
September 16, 2024
Today, Medicare Rights Center President Fred Riccardi spoke in support of the Capping Prescription Costs Act (S. 4671/H.R. 6347), legislation to extend key Inflation Reduction Act reforms to people with group health and marketplace plans.
Medicare Rights Center Celebrates the Anniversary of the Inflation Reduction Act and Applauds Monumental Prescription Drug Savings
August 15, 2024
–Statement by Fred Riccardi, president of the Medicare Rights Center– New York, NY—As we celebrate two years since the passage
Biden-Harris Administration Announces Billions in Savings from Drug Price Negotiations
August 15, 2024
In a historic first, the Biden-Harris administration today announced the results of the initial round of drug price negotiation made